Important Safety Information
Prescribing Information
Patient Site

Important Safety Information
Prescribing Information
Patient Site

HIV Treatment
Considerations
DHHS Guidelines:
Weight Patients at Risk:
Weight Real-World Data:
INSTI vs PI Patient POV DHHS Guidelines:
Rapid Initiation Patients at Risk:
HGBR M184V/I Prevalence
Efficacy
Treatment-Naïve
Patients Rapid Initiation
Patients Virologically
Suppressed Patients
Resistance
Summary
Safety &
Tolerability
Adverse Event
Profile GI Tolerability Weight Change Real-World Data:
SYMTUZA^® vs
BIC/FTC/TAF Neuropsychiatric
Tolerability Patient Satisfaction
Dosing &
Administration
Dosing Patient Satisfaction STR Pill Guide Coadministration Darunavir Dosing
Simplified
Support & Treatment
Resources
Resources SYMply Start^®CoverMyMeds^®Request
Samples Coverage in
Your Area Switch DRV Patients
to SYMTUZA^®
Important Safety Information
Patient Site
Prescribing Information
Stay Connected

Site Map

Important Safety Information
Prescribing Information
Patient Site

Home
HIV Treatment Considerations
Efficacy
Resistance Summary
Safety & Tolerability
Dosing & Administration
Support & Treatment Resources

Legal Notice
Privacy Policy
Medical Information Center
Contact Us
Site Map
CoverMyMeds
Find Coverage

Distributed by: Janssen Therapeutics, Division of Janssen Products, LP, a Johnson & Johnson company, Titusville, NJ 08560

© Janssen Therapeutics, Division of Janssen Products, LP 04/24 cp-282967v4. All rights reserved.

No footer content fetched

Last Updated April 2024

Medical Information Center Contact Us Site Map CoverMyMeds Coverage In Your Area

Last Updated April 2024

No footer links content fetched